U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. News & Events (Medical Devices)
  4. Workshops & Conferences (Medical Devices)
  5. Webinar - Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics: Final Guidance - November 1, 2018 - 11/01/2018 - 11/01/2018
  1. Workshops & Conferences (Medical Devices)

Webcast

Event Title
Webinar - Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics: Final Guidance - November 1, 2018
November 1, 2018

Date:
November 1, 2018
Time:
11:00 AM - 12:30 PM ET
Organized By:
Organizer

Webinar Materials

As technology continues to evolve, medical devices reviewed under the premarket notification (510(k)) process often have technological characteristics that differ from those of a legally marketed predicate device. On September 24, 2018, the FDA released a final guidance about the factors the FDA considers when evaluating benefits and risks of a new device compared to a predicate device during a 510(k) review when the FDA has determined that the intended use of the device is the same, but there are different technological characteristics. The recommendations in the final guidance do not change the 510(k)premarket review standard or require 510(k) submitters to provide additional performance data beyond what would normally be requested during the review process.

Back to Top